Taytay launches free kidney disease screening to catch silent condition early

Thirteen million Filipinos are walking around with chronic kidney disease right now, and most of them don't know it. That's one in nine people in the country living with a condition that typically announces itself only after it has already done serious damage—which is precisely why the Municipality of Taytay decided to bring the screening to them instead of waiting for them to find it.

Chronic kidney disease is a silent killer in the medical sense. The disease progresses quietly, often without symptoms, until a person's kidney function has deteriorated significantly or they suddenly feel sick enough to seek care. By then, the window for prevention has narrowed considerably. Early detection changes that equation entirely. If someone knows they're at risk—if they understand their kidney health numbers before crisis hits—they can access treatment, adjust their lifestyle, and slow or stop the disease's progression. The difference between catching it early and catching it late can mean the difference between managing a condition and spending the rest of your life on dialysis.

This understanding drove the creation of "Iwas Dialysis, Ligtas Kidneys: Get CheCKD Habang Maaga Pa!"—a free screening program launched by Taytay's municipal government in partnership with Boehringer Ingelheim Philippines and supported by the community organization Angat Taytay. The program is straightforward in its ambition: bring kidney health screening directly into neighborhoods, teach residents what their numbers mean, and give them the knowledge to act before the disease becomes an emergency. It aligns with the country's Universal Healthcare Act, which mandates that preventive care should be accessible to all.

In just two months, the program screened nearly four thousand residents across Taytay's barangays. That number alone suggests something important—people showed up. They wanted to know their kidney health status. The municipal government and its partners held screening sessions in different neighborhoods from August 8 through August 23, and the response was strong enough that they scheduled additional rounds. Two more screening dates were set for late August: one on the 29th in Sitio Bayabas Purok 1 and another on the 30th in Sitio Bayabas Purok 5.

Dr. Greta Cortez, Head of Medicine at Boehringer Ingelheim Philippines, framed the work as fundamentally about access. "Early detection can make a meaningful difference in Chronic Kidney Disease, and it begins with improving access to screening in communities that need it most," she said. The company's role, as she described it, was to work with local governments and healthcare providers to move screening out of clinics and into the places where people actually live.

Aldwin Aguinaldo, Taytay's Municipal Health Officer, articulated a different angle on the same work. "The best healthcare is the illness that never happens," he said. Prevention, in his view, is not just medically sound—it's the most compassionate and cost-effective thing a local government can do. A screening program costs far less than treating advanced kidney disease. More than that, though, early detection gives people something that medicine alone cannot: time to act, knowledge of their condition, and the chance to change course before their kidneys fail. That's what Aguinaldo meant when he said the program gives residents "something more valuable than medicine—we give them time, knowledge, and the chance to act early."

The program's expansion through August suggests this is not a one-time initiative. Taytay is building infrastructure for ongoing screening, reaching more barangays, and normalizing the idea that kidney health is something worth checking regularly, especially for people at higher risk. For a disease that typically hides until it's too late, that shift in approach—from reactive treatment to proactive screening—could reshape health outcomes across the municipality.